British Biomedical Bulletin is an open access peer reviewed and quarterly published research journal that publishes articles in the field of Biomedical Science. It is an international journal to encourage research publication to research scholars, academicians, professionals and students engaged in their respective field.
Our mission is to advance research by working to develop and maintain competence, ethics and integrity and the highest professional standards in the specialty for the benefit of the public. The faculty seeks, through its activities, to bring about an improvement in research of the public.
BBB serves an intellectual audience that is interested in the latest research coming out of universities and industries around the world. The journal publishes research developments and disseminates them to an international audience.
SCOPE OF JOURNAL
Medical Microbiology, Clinical Virology, Clinical Epidemiology and Biomedical Science.
Author(s): Joseph Omololu-Aso, Oluwaseun Oluwatoyin Omololu-Aso, Anthonia Olufunke Oluduro, Olapeju O Ajayi, Adekunle Adejuwon, Olutobi Olufunmilayo Otusanya
Guidelines focusing on National core indicators tools and methodology for monitoring and evaluating of Roll Back Malaria in Nigeria, in conformity with other countries in Africa region has been develo ... Read More
Author(s): Cuncan Deng, Guihua Liu
Mesenchymal stem cells (MSCs) can self-renew and maintain a multi-lineage differentiation potential. The PI3K/Akt signalling pathway is an essential signalling pathway of protein synthesis with ... Read More
Author(s): Raziyeh Mousavi, Zahra Haghighi Fashi, Mahsa Hadipour Jahromy* and Rokhsna Rasooli
Background: Herbal medicine has been widely applied as effective remedy by extensive spectrum of cultures. Psychiatric patients usually don’t accept their disease and also refuse drug ther ... Read More
Author(s): Geelani S, Najar MR, Nabi S, Bashir Y, Bashir N, Bhat S, Manzoor F, Qadri M, Zafar MS, Bhat BH and Rasool J
A number of emerging therapeutic options are currently being evaluated for the treatment of MDS that will, add to the treatment options for patients who are ineligible to receive HSCT or intensi ... Read More
Author(s): Guru Prasad Manderwad
All Published work is licensed under a Creative Commons Attribution 4.0 International License
Copyright © 2017 All rights reserved. iMedPub Last revised : October 14, 2017